formaldehyde has been researched along with Myasthenia Gravis in 1 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djanian, AY | 1 |
| Witebsky, E | 1 |
| Beutner, EH | 1 |
1 other study available for formaldehyde and Myasthenia Gravis
| Article | Year |
|---|---|
Formalinized tanned cell hemagglutination test for demonstration of autoantibodies in myasthenia gravis.
Topics: Arthritis, Rheumatoid; Autoantibodies; Fluorescent Antibody Technique; Formaldehyde; Hemagglutinatio | 1966 |